Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11787851 Optimized factor VIII gene

Patent 11787851 was granted and assigned to Bioverativ on October, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Siyuan Tan

Robert T. Peters

Date of Patent

October 17, 2023

Patent Application Number

16452010

Date Filed

June 25, 2019

Patent Citations

US Patent 8734809 AAV's and uses thereof

US Patent 9050269 Protection of virus particles from phagocytosis by expression of CD47

US Patent 9050318 Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof

US Patent 9061059 Modified polynucleotides for treating protein deficiency

US Patent 9169491 Virus purification

US Patent 10000748 Factor IX variants with clotting activity in absence of their cofactor and/or with increased F.IX clotting activity and their use for treating bleeding disorders

US Patent 10058624 Recombinant promoters and vectors for protein expression in liver and use thereof

US Patent 10370431 Optimized factor VIII gene

...

Patent Primary Examiner

Michael Szperka

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11787851 Optimized factor VIII gene

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool